LongCovid
An excelent systematic review of trials currently investigating treatment for Post-Acute COVID Syndrome (PACS)/longCOVID has been published by the Clinical Microbiology and Infection (CMI).
The review identified 388 registered trials exploring 144 unique interventions for PACS. Most target general alleviation of symptoms. As highlighted by this review, there is an urgent need for further high-quality and methodologically robust PACS treatment trials.
The Lancet Respiratory Medicine has just published two excellent Long COVID reviews: the first one on the multi-system sequelae and the second one on the mechanisms of brain/neurologic…
A group of researchers from the University of Helsinki leaded by Prof. Jari Koistinaho and Dr. Dr. Giuseppe Balistreri, in collaboration with the University of Eastern Finland, recently published…
As recently reported by Science Alert, a relevant study of around 500,000 medical records suggests that severe viral infections increase the risk of neurodegenerative diseases like Parkinson’s and Alzheimer’s. The study, published…
A recent preprint found SARS-CoV-2 antigens in plasma up to 14 months post-COVID. Could these antigens have a causal role in Long Covid patients? Additional work will be needed to…